Q3 2021 Iovance Biotherapeutics Inc Earnings Call Transcript
Welcome to the Iovance Biotherapeutics Third Quarter and Year-to-date 2021 Financial Results. My name is Andrew, and I'll be your operator for today's call. (Operator Instructions) Please note that today's conference is being recorded.
I will now turn the call over to Sara Pellegrino, Vice President, Investor and Public Relations at Iovance. Sara, you may begin.
Thank you, operator. Good afternoon, and thank you for joining us. Speaking on today's call, we have Fred Vogt, our Interim President and Chief Executive Officer; Igor Bilinsky, our Chief Operating Officer; Jim Ziegler, our Senior Vice President, Commercial; Dr. Friedrich Finckenstein, our Chief Medical Officer; and Jean-Marc Bellemin, our Chief Financial Officer. Dr. Madan Jagasia our Senior Vice President, Medical Affairs; and Laurel Todd, Vice President of Policy are also on the call to participate in the Q&A session.
This afternoon, we issued a press release that can be found on our website at
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |